SOAR Webinar

SOAR Webinar

**At this time, the SOAR study has reached capacity for conference participation. However, there still may be opportunities for research participation at the family conference due to cancellations or addition of other opportunities. If you would like to be placed on a...

Sci Spotlight- February 2025

Updates from the Director of Scientific & Clinical Initiatives February 2025 February has been a challenging month for science in America. Cuts to NIH funding have threatened scientific research, including for Dup15q syndrome. In the past few weeks, I have been...

Sci Spotlight Draft

Updates from the Director of Scientific & Clinical Initiatives August 2024 It is my pleasure to introduce myself as the new full-time Director of Scientific and Clinical Initiatives with the Dup15q Alliance! The Dup15q community has been a part of my life for...
FDA Issues Recall On Clonazepam Orally Disintegrating Tablets

FDA Issues Recall On Clonazepam Orally Disintegrating Tablets

The Dup15q Alliance is aware of the recent release by the FDA regarding Clonazepam Orally Disintegrating Tablets USP by Endo USA due to potential product carton strength mislabeling. Ongoing investigation identified the possibility that the affected clonazepam product...